The purpose of this prospective trial is to demonstrate the safety and performance of the Second Generation Anti-Microbial vascular graft in the treatment of aneurysmal and occlusive diseases of the abdominal aorta.

Inclusion Criteria:

• Is 18 - 85 years of age
• Is presenting with an aorto-iliac occlusion (obstruction of flow) or stenosis, or aorto-iliac aneurysm and is eligible for a revascularization with a bifurcated graft
• Is affiliated with a social welfare organization system
• Is willing to participate in the clinical evaluation after signature of the informed consent
• Is able to attend all follow up visits and diagnostics and laboratory exams required by the present protocol

Exclusion Criteria:

• Is treated as an emergency
• Is included in another investigation
• Is pregnant or lactating, or a woman of childbearing potential unwillint to use an effective form of contraception for the duration of the trial
• Has a known allergy to the material device used
• Has previous aorto-iliac bypass or replacement